<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR64" class="ref">
 <label class="label">64.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Bortul</surname>
    <given-names class="given-names">R</given-names>
   </name>
   <name class="name">
    <surname class="surname">Tazzari</surname>
    <given-names class="given-names">PL</given-names>
   </name>
   <name class="name">
    <surname class="surname">Billi</surname>
    <given-names class="given-names">AM</given-names>
   </name>
   <name class="name">
    <surname class="surname">Tabellini</surname>
    <given-names class="given-names">G</given-names>
   </name>
   <name class="name">
    <surname class="surname">Mantovani</surname>
    <given-names class="given-names">I</given-names>
   </name>
   <name class="name">
    <surname class="surname">Cappellini</surname>
    <given-names class="given-names">A</given-names>
   </name>
   <etal class="etal"/>
  </person-group>
  <article-title class="article-title">Deguelin, a PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway</article-title>
  <source class="source">Br J Haematol.</source>
  <year class="year">2005</year>
  <volume class="volume">129</volume>
  <fpage class="fpage">677</fpage>
  <lpage class="lpage">686</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1111/j.1365-2141.2005.05504.x</pub-id>
  <?supplied-pmid 15916691?>
  <pub-id pub-id-type="pmid" class="pub-id">15916691</pub-id>
 </element-citation>
</ref>
